These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Boyer W. Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804 [Abstract] [Full Text] [Related]
24. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. Rickels K, Schweizer E, Weiss S, Zavodnick S. Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223 [Abstract] [Full Text] [Related]
25. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder. Feighner JP, Meredith CH, Frost NR, Chammas S, Hendrickson G. Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925 [Abstract] [Full Text] [Related]
26. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment. Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O. Eur Arch Psychiatry Clin Neurosci; 1991 Oct; 241(1):22-30. PubMed ID: 1832302 [Abstract] [Full Text] [Related]
27. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. Schweizer E, Patterson W, Rickels K, Rosenthal M. Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566 [Abstract] [Full Text] [Related]
28. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia. Klerman GL. J Psychiatr Res; 1990 Aug; 24 Suppl 2():27-41. PubMed ID: 1980697 [Abstract] [Full Text] [Related]
32. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine. Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R. Acta Psychiatr Scand Suppl; 1991 Aug; 365():28-32. PubMed ID: 1862731 [Abstract] [Full Text] [Related]
33. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study. Sheehan DV, Raj AB, Harnett-Sheehan K, Soto S, Knapp E. Acta Psychiatr Scand; 1993 Jul; 88(1):1-11. PubMed ID: 8372689 [Abstract] [Full Text] [Related]
34. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients. Mendels J, Schless AP. J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131 [Abstract] [Full Text] [Related]
35. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR. J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889 [Abstract] [Full Text] [Related]
36. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. Jonas JM, Cohon MS. J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888 [Abstract] [Full Text] [Related]
37. Drug treatment of panic disorder. Rosenberg R. Pharmacol Toxicol; 1993 Jun; 72(6):344-53. PubMed ID: 8103214 [Abstract] [Full Text] [Related]
38. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure. Cox BJ, Endler NS, Lee PS, Swinson RP. J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535 [Abstract] [Full Text] [Related]
40. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Bakish D, Hooper CL, Filteau MJ, Charbonneau Y, Fraser G, West DL, Thibaudeau C, Raine D. Psychopharmacol Bull; 1996 Sep; 32(1):135-41. PubMed ID: 8927663 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]